Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Laryngeal Neoplasms × Vemurafenib × Clear all

Sponsor

Conditions

Melanoma 29 Neoplasms 7 Neoplasm Metastasis 3 Skin Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Lymphoma, Non-Hodgkin 1 Leukemia, Hairy Cell 1 Histiocytosis, Langerhans-Cell 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Glioma 1 Ependymoma 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Cetuximab 6 Cisplatin 5 Radiotherapy, Intensity-Modulated 4 pembrolizumab 2 durvalumab 2 Fluorouracil 2 Docetaxel 2 Celecoxib 2 Carboplatin 2 Bupropion 2 130-nm albumin-bound paclitaxel 2 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Radiotherapy 1 Radiation 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 Immunoglobulin G 1 Hydroxyurea 1 Gene Expression Profiling 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Erlotinib Hydrochloride 1 Early Intervention, Educational 1 Drug Therapy 1 Disulfides 1 Dihematoporphyrin Ether 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡